Adjusted* relative risk (95% CI) of maintaining a Medication Possession Ratio ≥0.8 over 1 year and up to 3 years following an ACS hospitalisation
| 1 year | Up to 3 years | |
|---|---|---|
| Age 35–44 years | 0.84 (0.77 to 0.91) | 0.75 (0.67 to 0.83) |
| Age 45–54 years | 0.97 (0.93 to 1.01) | 0.94 (0.90 to 0.99) |
| Age 55–64 years | ||
| Age 65–74 years | 1.00 (0.97 to 1.03) | 1.02 (0.99 to 1.06) |
| Age 75–84 years | 0.96 (0.93 to 1.00) | 0.97 (0.94 to 1.01) |
| Female | 0.95 (0.93 to 0.98) | 0.94 (0.91 to 0.96) |
| European/other | ||
| Māori | 0.88 (0.84 to 0.92) | 0.87 (0.83 to 0.92) |
| Pacific | 0.82 (0.76 to 0.89) | 0.82 (0.75 to 0.90) |
| Indian | 1.01 (0.94 to 1.08) | 0.98 (0.91 to 1.07) |
| STEMI | 1.18 (1.14 to 1.22) | 1.15 (1.10 to 1.19) |
| Coronary procedure | 1.24 (1.21 to 1.27) | 1.22 (1.19 to 1.25) |
| Previous CVD | 0.94 (0.91 to 0.96) | 0.96 (0.93 to 0.98) |
| Prior statin use | 1.57 (1.53 to 1.62) | 1.56 (1.52 to 1.61) |
All figures in parenthesis are 95% CIs.
*Adjusted for the variables shown in this table: age, gender, ethnicity, STEMI diagnosis, coronary procedure within 30 days of admission, previous CVD and statin use in the 90 days before admission.
ACS, acute coronary syndrome; CVD, cardiovascular disease; STEMI, ST elevation myocardial infarction.